Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Common Stock: €25.87 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TJJ Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
28 GF Score
Price €0.02
GF Value €0.01
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tianjin TEDA Biomedical Engineering Co Common Stock?

Tianjin TEDA Biomedical Engineering Co FRA:TJJ -2.27% 28 Common Stock is €25.87 Mil as of Dec. 2025. GuruFocus rates FRA:TJJ with a GF Score™ of 28/100 and a GF Value™ of €0.01 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Tianjin TEDA Biomedical Engineering Co's quarterly common stock increased from Dec. 2024 (€24.85 Mil) to Jun. 2025 (€25.77 Mil) and increased from Jun. 2025 (€25.77 Mil) to Dec. 2025 (€25.87 Mil).

Tianjin TEDA Biomedical Engineering Co's annual common stock increased from Dec. 2023 (€24.33 Mil) to Dec. 2024 (€24.85 Mil) and increased from Dec. 2024 (€24.85 Mil) to Dec. 2025 (€25.87 Mil).

Tianjin TEDA Biomedical Engineering Co Common Stock Historical Data

* Premium members only.

The historical data trend for Tianjin TEDA Biomedical Engineering Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin TEDA Biomedical Engineering Co Common Stock Chart

Tianjin TEDA Biomedical Engineering Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.32 25.65 24.33 24.85 25.87

Tianjin TEDA Biomedical Engineering Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.33 24.26 24.85 25.77 25.87
FRA:TJJ
28GF Score
Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin TEDA Biomedical Engineering Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €25.87 Mil mean?
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) has a Common Stock of €25.87 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors.
Is Tianjin TEDA Biomedical Engineering Co's Common Stock too high?
Tianjin TEDA Biomedical Engineering Co's current Common Stock is €25.87 Mil. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's Common Stock compare to CTVA and CF?
Tianjin TEDA Biomedical Engineering Co's Common Stock of €25.87 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Agriculture company?
A good Common Stock depends on the Agriculture industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. Tianjin TEDA Biomedical Engineering Co's current Common Stock is €25.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 115% above its estimated fair value. The current Common Stock is €25.87 Mil. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (FRA:TJJ), the current Common Stock is €25.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued. The current stock price of €0.02 is trading 115% above its estimated GF Value™ of €0.01. GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.

Key valuation signals for FRA:TJJ:

  • Common Stock: €25.87 Mil
  • GF Value™: €0.01 vs. price of €0.02 (115% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the FRA:TJJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tianjin TEDA Biomedical Engineering Co Business Description

Other Exchanges 08189:Hong Kong
Address No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score

Get the complete analysis for FRA:TJJ

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.01
GF Value